Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH 

Madrigal Pharmaceuticals |

Chair: Michael Roden (GER)

12:00 – 12:05IntroductionMichael Roden (GER)
12:05 – 12:20NASH: a growing unmet therapeutic needJörn Schattenberg (GER)
12:20 – 12:35The underestimated role of thyroid hormone pathway in the pathophysiology of NASHEveline Bruinstroop (NLD)
12:35 – 12:50Discussion and Q&AsMichael Roden (GER)
Jörn Schattenberg (GER)
Eveline Bruinstroop (NLD)
12:50 – 13:00Key take home messages and close Michael Roden (GER)